InvestorsHub Logo
Followers 66
Posts 1221
Boards Moderated 0
Alias Born 04/02/2020

Re: humble howard post# 85527

Friday, 06/19/2020 3:07:37 PM

Friday, June 19, 2020 3:07:37 PM

Post# of 233004
I’m not convinced what the sales multiple should ultimately be for CytoDyn but I respectfully disagree with a 1.7x multiple. There are a myriad of companies trading in excess of 20x multiple and investors are willing to pay for the growth potential. CytoDyn’s potential revenue stream will definitely come into play in the final analysis... I’m personally comfortable with 10x for Leronlimab’s market potential... Only time will tell...

Here’s an interesting take from Motley Fools
https://www.fool.com/investing/2019/04/04/why-do-so-many-biotech-stocks-have-such-high-ps-va.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News